Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,400 | 71 | 57.7% |
| Food and Beverage | $16,306 | 1,345 | 42.0% |
| Education | $92.58 | 11 | 0.2% |
| Gift | $18.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | $22,912 | 107 | $0 (2022) |
| Novo Nordisk Inc | $2,559 | 277 | $0 (2024) |
| Lilly USA, LLC | $1,093 | 140 | $0 (2024) |
| Amgen Inc. | $976.01 | 63 | $0 (2024) |
| MannKind Corporation | $960.91 | 90 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $937.38 | 66 | $0 (2024) |
| Dexcom, Inc. | $914.07 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $779.59 | 77 | $0 (2020) |
| Insulet Corporation | $691.97 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $662.10 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $923.19 | 41 | Dexcom, Inc. ($160.13) |
| 2023 | $566.47 | 26 | Dexcom, Inc. ($136.76) |
| 2022 | $890.45 | 52 | Novo Nordisk Inc ($138.32) |
| 2021 | $538.55 | 41 | Novo Nordisk Inc ($187.19) |
| 2020 | $6,574 | 132 | Tandem Diabetes Care, Inc. ($5,328) |
| 2019 | $13,806 | 406 | Tandem Diabetes Care, Inc. ($9,377) |
| 2018 | $9,487 | 370 | Tandem Diabetes Care, Inc. ($5,980) |
| 2017 | $6,030 | 360 | Tandem Diabetes Care, Inc. ($2,203) |
All Payment Transactions
1,428 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $94.14 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Bone Health | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/24/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Durable Pump | ||||||
| 09/17/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.52 | General |
| 08/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Endocrinology | ||||||
| 08/08/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $25.98 | General |
| 08/01/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes Care | ||||||
| 07/15/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 06/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Endocrinology | ||||||
| 06/06/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Durable Pump | ||||||
| 05/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,447 | 15,015 | $650,060 | $351,522 |
| 2022 | 11 | 1,578 | 15,251 | $559,160 | $340,346 |
| 2021 | 10 | 1,433 | 13,049 | $464,026 | $288,453 |
| 2020 | 12 | 882 | 8,586 | $310,210 | $175,625 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 118 | 12,780 | $385,680 | $233,182 | 60.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 252 | 418 | $99,777 | $51,610 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 406 | 581 | $111,155 | $47,919 | 43.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 149 | 379 | $21,260 | $9,403 | 44.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 38 | 38 | $10,968 | $2,747 | 25.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 118 | 213 | $10,106 | $2,302 | 22.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 132 | 189 | $3,931 | $1,738 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $3,313 | $1,390 | 41.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 210 | 392 | $3,870 | $1,231 | 31.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 121 | 12,781 | $305,448 | $216,121 | 70.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 432 | 610 | $100,416 | $50,408 | 50.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 241 | 385 | $78,755 | $47,781 | 60.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 143 | 346 | $17,300 | $8,634 | 49.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 53 | 55 | $15,868 | $4,169 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $10,000 | $3,122 | 31.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 122 | 215 | $10,750 | $2,385 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,500 | $2,058 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 134 | 208 | $4,167 | $1,975 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 34 | $4,224 | $1,867 | 44.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 253 | 572 | $5,732 | $1,825 | 31.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 116 | 11,100 | $254,401 | $180,570 | 71.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 378 | 486 | $80,136 | $43,287 | 54.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 229 | 317 | $64,900 | $41,004 | 63.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 124 | 252 | $12,600 | $6,553 | 52.0% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 60 | 63 | $18,270 | $5,503 | 30.1% |
About Dr. Pallavy Reddy, MD
Dr. Pallavy Reddy, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740277664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pallavy Reddy, MD has received a total of $38,816 in payments from pharmaceutical and medical device companies, with $923.19 received in 2024. These payments were reported across 1,428 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,400).
As a Medicare-enrolled provider, Reddy has provided services to 5,340 Medicare beneficiaries, totaling 51,901 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Dublin, OH
- Active Since 10/05/2005
- Last Updated 04/07/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1740277664
Products in Payments
- t-slim insulin pump (Device) $17,560
- t:slim X2 insulin pump (Device) $5,328
- Ozempic (Drug) $1,235
- AFREZZA (Drug) $960.91
- JARDIANCE (Drug) $765.90
- INVOKANA (Drug) $732.43
- Omnipod (Device) $691.97
- FARXIGA (Drug) $572.45
- Korlym (Drug) $522.66
- UNITHROID (Drug) $509.99
- Victoza (Drug) $451.77
- HUMULIN (Drug) $434.85
- Dexcom G6 Transmitter (Medical Supply) $429.64
- Repatha (Biological) $389.52
- V-GO (Device) $363.69
- Vascepa (Drug) $344.00
- TOUJEO (Drug) $322.13
- Saxenda (Drug) $306.38
- Tymlos (Biological) $287.86
- EVENITY (Biological) $286.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Dublin
Dr. Jennifer Rittenberry, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $259,875
Dr. John Stafford, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,364
Deval Bhatt, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $416.46
Taylor Cater, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $318.60
Traci Tupper, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $244.56
Dr. Aruna Chakravorty, M.d., Phd, M.D., PHD
Endocrinology, Diabetes & Metabolism — Payments: $175.79